CSPG4 and melanoma: In hepatocellular carcinoma, Glypican-3-specific CAR-NK T-cells also mediated potent antitumor activity while the chondroitin sulfate proteoglycan 4 (CSPG4) CAR-NK T-cells demonstrated the efficacy against melanoma (141, 142).